Dr. Danuta Kozbor joined the staff of the Department of Immunology at Roswell Park Cancer Institute (RPCI) in 2002, as Associate Professor of Immunology and Microbiology. She completed her training as a Postdoctoral Fellow of the National Cancer Institute of Canada at the Wistar Institute in Philadelphia, PA, in 1986.Previously, Dr. Kozbor held a faculty position at Thomas Jefferson University in Philadelphia, PA, the Center for Neurovirology and Cancer Biology at Temple University, Philadelphia, PA. She was also a visiting professor at Kumamoto University, Japan.Dr. Kozbor served as a member of the editorial board of Clinical and Diagnostic Laboratory Immunology and NIAD/NIH study sections on the HIV Vaccine Design and Development Teams for Prevention and Treatment.

to elucidate molecular and cellular mechanisms of antitumor activities of immuno-oncolytic viral vectors against metastatic tumors. We design novel approaches to enhance the antitumor efficacy of oncolytic virotherapy by expressing therapeutic genes such as the CXCR4 antagonist, augmenting spread of the virus within tumors, and designing novel therapeutic approaches by combining agents with both cytotoxic and immunogenic effects on tumor cells.